4D MOLECULAR THERAPEUTICS IN shareholders Q3 2023

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

4D MOLECULAR THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
RHUMBLINE ADVISERS 58,449$744,0450.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 258,508$3,290,8070.00%
Itau Unibanco Holding S.A. 1,499$19,0820.00%
GEODE CAPITAL MANAGEMENT, LLC 741,665$9,442,3850.00%
STATE STREET CORP 1,717,120$21,858,9380.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 27,159$345,7340.00%
NORTHERN TRUST CORP 363,725$4,630,2200.00%
CITIGROUP INC 54,699$696,3180.00%
BARCLAYS PLC 73,935$9410.00%
HARBOUR INVESTMENTS, INC. 25$3180.00%
NEW YORK STATE COMMON RETIREMENT FUND 13,813$1760.00%
UBS Group AG 44,897$571,5390.00%
NISA INVESTMENT ADVISORS, LLC 1,870$23,8050.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 11,187$142,4110.00%
DEUTSCHE BANK AG\ 15,569$198,1930.00%
CREDIT SUISSE AG/ 25,744$327,7210.00%
UBS ASSET MANAGEMENT AMERICAS INC 23,588$300,2750.00%
VOYA INVESTMENT MANAGEMENT LLC 15,880$202,1520.00%
GOLDMAN SACHS GROUP INC 158,274$2,014,8280.00%
Tower Research Capital LLC (TRC) 1,119$14,2440.00%
External links

This page lists 4D MOLECULAR THERAPEUTICS IN's shareholders in Q3 2023. To view 4D MOLECULAR THERAPEUTICS IN's shareholder history, click here.